- Home
- INBS vs TRAW Comparison
INBS vs TRAW Comparison
Compare INBS & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- TRAW
- Stock Information
- Founded
- INBS 2016
- TRAW 1998
- Country
- INBS United States
- TRAW United States
- Employees
- INBS N/A
- TRAW N/A
- Industry
- INBS Medical Specialities
- TRAW
- Sector
- INBS Health Care
- TRAW
- Exchange
- INBS Nasdaq
- TRAW NYSE
- Market Cap
- INBS 8.7M
- TRAW 7.8M
- IPO Year
- INBS N/A
- TRAW 2013
- Fundamental
- Price
- INBS $1.24
- TRAW $1.10
- Analyst Decision
- INBS
- TRAW
- Analyst Count
- INBS 0
- TRAW 0
- Target Price
- INBS N/A
- TRAW N/A
- AVG Volume (30 Days)
- INBS 113.6K
- TRAW 128.9K
- Earning Date
- INBS 05-13-2025
- TRAW 05-15-2025
- Dividend Yield
- INBS N/A
- TRAW N/A
- EPS Growth
- INBS N/A
- TRAW N/A
- EPS
- INBS N/A
- TRAW N/A
- Revenue
- INBS $2,936,472.00
- TRAW $226,000.00
- Revenue This Year
- INBS $280.88
- TRAW $3.81
- Revenue Next Year
- INBS $126.26
- TRAW $30.43
- P/E Ratio
- INBS N/A
- TRAW N/A
- Revenue Growth
- INBS 3.87
- TRAW N/A
- 52 Week Low
- INBS $1.00
- TRAW $1.32
- 52 Week High
- INBS $3.04
- TRAW $19.44
- Technical
- Relative Strength Index (RSI)
- INBS 43.94
- TRAW 25.77
- Support Level
- INBS $1.16
- TRAW $1.05
- Resistance Level
- INBS $1.43
- TRAW $1.54
- Average True Range (ATR)
- INBS 0.10
- TRAW 0.18
- MACD
- INBS 0.02
- TRAW 0.02
- Stochastic Oscillator
- INBS 42.42
- TRAW 20.63
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.